SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Biotech Bay
The Day In Review: FDA Pays $500 Million For Cancer Drug
August 28, 2006
 · 
1 min read
FDA
Herceptin Cancer Drug Wins Final British Go-Ahead
August 23, 2006
 · 
1 min read
Biotech Bay
Brits Reject Genentech, Inc., ImClone Systems Incorporated Drugs As Too Expensive
August 21, 2006
 · 
1 min read
Biotech Beach
Genentech, Inc. Signs Groundbreaking License
August 10, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Centient Consulting Inc. Beats Estimates
July 12, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Curis, Inc. And Genentech, Inc. Stop Cancer Trial
July 12, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Genentech, Inc. Stops Avastin Trial
June 27, 2006
 · 
1 min read
Biotech Beach
The Day In Review: Sleep Drug Data From Conference
June 21, 2006
 · 
1 min read
Policy
Major Drug Company Blocks Cheap Blindness Cure To Market More Expensive One
June 19, 2006
 · 
1 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Policy
Curis, Inc. Partner Genentech Sends Cancer Drug to FDA
September 12, 2011
 · 
5 min read
Business
Biologics, Inc. (NC) Selected by Genentech as Strategic Partner for Launch of New Targeted Oral Oncology Therapy
September 8, 2011
 · 
1 min read
Business
Galapagos NV and Genentech Extend Drug Discovery Collaboration for About $35 Million
August 18, 2011
 · 
2 min read
Business
Array BioPharma, Inc., Genentech Ink $713 Million Oncology Pact
August 9, 2011
 · 
4 min read
Deals
Gilead Sciences, Inc. to Purchase Biologics Plant From Genentech
August 9, 2011
 · 
3 min read
Policy
Genentech Takes Another Shot at Convincing FDA to Keep Avastin Available for “Appropriate” Breast Cancer Patients
August 8, 2011
 · 
1 min read
Drug Development
Genentech’s New Drug Shows Promise in Fighting Breast Cancer
August 5, 2011
 · 
1 min read
Drug Development
Genentech Drug Impresses in Phase III Trial; to Seek Approval by Year End
July 15, 2011
 · 
8 min read
Policy
Nevada State Judge Denies Roche and Genentech’s Motions to Dismiss PDL BioPharma, Inc.'s Complaint
July 11, 2011
 · 
3 min read
Drug Development
Genentech Announces Two Pivotal Phase III Lucentis Studies Showed Patients With Diabetic Macular Edema Experienced Significant Improvements in Vision and Fewer Developed More Advanced Retinopathy
June 28, 2011
 · 
3 min read
Load More